11:23 AM EST, 01/08/2026 (MT Newswires) -- Omada Health ( OMDA ) said Thursday that a 12-month real-world analysis of 965 participants in its enhanced GLP-1 Care Track companion program indicates the program supports long-term weight loss.

Participants who remained in the program and on their medication for 12 months lost an average 18.4% of body weight, compared with 11.9% reported in published real-world studies.

Including participants who did not remain on medication for the full year, the average weight loss was 16.3%.

Participants who discontinued GLP-1 therapy before one year lost an average of 13.1%, compared with 6.8% in similar patients outside the program.

Price: 16.47, Change: -0.10, Percent Change: -0.60